Many of us have a bottle of hydrogen peroxide at home. For decades, it was a staple in first aid kits, and even though its ...

Benzoyl peroxide (BP) has long been a go-to acne treatment, but recent findings have raised concerns about its safety. A report from Valisure, an independent testing laboratory, suggests that benzoyl ...

Department of Basic Sciences, Faculty of Engineering, Necmettin Erbakan University, Konya 42140, Türkiye BITAM-Science and Technology Research and Application Center, Necmettin Erbakan University, ...

Hydrogen's climate credentials also depend on how it is produced. Japan wants to become a hydrogen fuel leader to meet its net-zero goals, but one blockbuster project is hanging in the balance ...

Airbus has reaffirmed its commitment to hydrogen-powered aviation, pushing forward with its ZEROe project. The company now expects to debut a commercially viable hydrogen aircraft by the late ...

Premier David Eby travelled to Prince George last January to launch a project to power a Canfor mill with hydrogen captured from a chemical facility. The project is one of six hydrogen projects ...

Merck's stock trades at a low valuation as investors worry about Keytruda's looming patent cliff. The company is looking to a new, subcutaneous formulation, which could help sales remain strong ...

40% of Merck & Co., Inc.'s revenues are driven by cancer med Keytruda, which faces patent expiry by 2028, posing a significant risk to future earnings and share price value. The company is ...

Merck MRK announced that it has entered into an exclusive licensing deal with China-based Jiangsu Hengrui Pharmaceuticals (Hengrui Pharma) for the latter’s investigational oral small-molecule ...

March 26 (Reuters) - The U.S. Department of Energy is weighing funding cuts to four of seven hydrogen hubs that were selected under a $7 billion federal program, according to a source briefed on ...

Merck & Co. will pay as much as $2 billion for the rights to Jiangsu Hengrui Pharmaceuticals Co.’s experimental heart drug, the US drugmaker’s second recent foray into China for a novel medicine.